CHIKUNGUNYA VIRUS
Clinical trials for CHIKUNGUNYA VIRUS explained in plain language.
Never miss a new study
Get alerted when new CHIKUNGUNYA VIRUS trials appear
Sign up with your email to follow new studies for CHIKUNGUNYA VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive vaccine trial aims to stop debilitating chikungunya virus
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine to prevent chikungunya, a virus that causes fever and severe joint pain. About 6,144 people aged 12 and older will receive either the vaccine or a placebo. Researchers will check if the vaccine safely prevents infection and reduces long-term joint p…
Matched conditions: CHIKUNGUNYA VIRUS
Phase: PHASE3 • Sponsor: Bavarian Nordic • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 01, 2026 00:00 UTC
-
New vaccine trial aims to protect kids from mosquito virus
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a vaccine against chikungunya virus in about 720 children aged 1 to under 12. The vaccine uses virus-like particles to train the immune system. Researchers will check if it is safe and triggers a strong immune response compared to a placebo.
Matched conditions: CHIKUNGUNYA VIRUS
Phase: PHASE3 • Sponsor: Bavarian Nordic • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:00 UTC